Synthetic Smac peptide enhances chemo-sensitivity of bladder cancer cells

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Huazhong University of Science and Technology. Medical Sciences

• Publication date

  2008-06-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11596-008-0317-0PMID 18563329
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Role of mitochondrial protein Smac/Diablo in regulation of apoptotic pathways].

  2006cited by this paper
• Synthetic Smac peptide enhances the effect of etoposide-induced apoptosis in human glioblastoma cell lines

  2006cited by this paper
• Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-xL in a strictly caspase-3-dependent manner in human carcinoma cells

  2004cited by this paper
• Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM).

  2004cited by this paper
• A high-throughput screen for identification of molecular mimics of Smac/DIABLO utilizing a fluorescence polarization assay.

  2003cited by this paper
• Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.

  2003cited by this paper
• SMAC Negatively Regulates the Anti-apoptotic Activity of Melanoma Inhibitor of Apoptosis (ML-IAP)*

  2002cited by this paper
• Mechanisms of caspase activation and inhibition during apoptosis.

  2002cited by this paper
• Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo

  2002cited by this paper
• The Antennapedia peptide penetratin translocates across lipid bilayers – the first direct observation

  2000cited by this paper
• Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain

  2000cited by this paper
• Apoptosis induced by anticancer drugs

  1992cited by this paper

• Inhibitor of apoptosis proteins as therapeutic targets in bladder cancer

  2023cites this paper
• Tumor necrosis factor‑related apoptosis‑inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first‑line chemotherapy.

  2020cites this paper
• Do we have biomarkers to predict response to neoadjuvant and adjuvant chemotherapy and immunotherapy in bladder cancer?

  2017cites this paper
• Drugs interfering with apoptosis in breast cancer.

  2011cites this paper
• Knockdown of Second Mitochondria-Derived Activator of Caspase Expression by RNAi Enhances Growth and Cisplatin Resistance of Human Lung Cancer Cells

  2010cites this paper
• Emerging apoptosis agonists for bladder cancer

  2009cites this paper